Yi-Jen Chen1,2, Hung-Pin Tu3, Chia-Ling Lee1,4, Wei-Chun Huang5,6,7, Jin-Shiou Yang7, Cyuan-Fong Li1, Chia-Hsin Chen1,8, Ko-Long Lin9. 1. Department of Physical Medicine and Rehabilitation, Kaohsiung Medical University Hospital. 2. Graduate Institute of Clinical Medicine. 3. Department of Public Health and Environmental Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University. 4. Department of Physical Medicine and Rehabilitation, Kaohsiung Municipal Hsiao-Kang Hospital. 5. Critical Care Center and Cardiovascular Medical Center, Kaohsiung Veterans General Hospital, Kaohsiung. 6. School of Medicine, National Yang-Ming University, Taipei. 7. Department of Physical Therapy, Fooyin University. 8. Department of Physical Medicine and Rehabilitation, School of Medicine, College of Medicine, Kaohsiung Medical University. 9. Department of Physical Medicine and Rehabilitation, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Abstract
BACKGROUND: The 6-minute walk test (6MWT) and cardiopulmonary exercise test (CPET) are exercise tests associated with physical function, quality of life and hemodynamic data in patients with pulmonary arterial hypertension (PAH). This study was conducted to assess correlations between exercise capacity, quality of life and disease functional classification, and to analyze the value of comprehensive assessments in predicting mortality in patients with PAH. METHODS: Fifty-four patients with PAH were enrolled. Comprehensive assessments including exercise capacity evaluated using the 6MWT and CPET, and health-related quality of life evaluated using the Short Form 36 (SF-36) questionnaire were performed in all participants. The patients were followed for 2 years with the end point of mortality. RESULTS: The survivors had a longer 6-minute walking distance, higher peak oxygen uptake and higher physical component score of the SF-36 than the non-survivors. In addition, exercise capacity combined with SF-36 predicted 2-year mortality in the patients with PAH. The patients with lower peak oxygen uptake (peak VO2 < 11.03 mL/kg/ min) and lower physical component score (score < 44.54) had a higher mortality rate than those with a higher peak VO2 and higher physical component score (adjusted hazard ratio = 19.95, p = 0.011). CONCLUSIONS: Comprehensive assessments of exercise capacity and quality of life can be used to predict 2-year mortality in patients with PAH.
BACKGROUND: The 6-minute walk test (6MWT) and cardiopulmonary exercise test (CPET) are exercise tests associated with physical function, quality of life and hemodynamic data in patients with pulmonary arterial hypertension (PAH). This study was conducted to assess correlations between exercise capacity, quality of life and disease functional classification, and to analyze the value of comprehensive assessments in predicting mortality in patients with PAH. METHODS: Fifty-four patients with PAH were enrolled. Comprehensive assessments including exercise capacity evaluated using the 6MWT and CPET, and health-related quality of life evaluated using the Short Form 36 (SF-36) questionnaire were performed in all participants. The patients were followed for 2 years with the end point of mortality. RESULTS: The survivors had a longer 6-minute walking distance, higher peak oxygen uptake and higher physical component score of the SF-36 than the non-survivors. In addition, exercise capacity combined with SF-36 predicted 2-year mortality in the patients with PAH. The patients with lower peak oxygen uptake (peak VO2 < 11.03 mL/kg/ min) and lower physical component score (score < 44.54) had a higher mortality rate than those with a higher peak VO2 and higher physical component score (adjusted hazard ratio = 19.95, p = 0.011). CONCLUSIONS: Comprehensive assessments of exercise capacity and quality of life can be used to predict 2-year mortality in patients with PAH.
Entities:
Keywords:
Comprehensive assessment; Exercise capacity; Pulmonary arterial hypertension; Quality of life
Authors: Miguel A Quiñones; Catherine M Otto; Marcus Stoddard; Alan Waggoner; William A Zoghbi Journal: J Am Soc Echocardiogr Date: 2002-02 Impact factor: 5.251
Authors: S Miyamoto; N Nagaya; T Satoh; S Kyotani; F Sakamaki; M Fujita; N Nakanishi; K Miyatake Journal: Am J Respir Crit Care Med Date: 2000-02 Impact factor: 21.405
Authors: Roland Wensel; Christian F Opitz; Stefan D Anker; Jörg Winkler; Gert Höffken; Franz X Kleber; Rakesh Sharma; Manfred Hummel; Roland Hetzer; Ralf Ewert Journal: Circulation Date: 2002-07-16 Impact factor: 29.690
Authors: Darren B Taichman; Jennifer Shin; Laryssa Hud; Christine Archer-Chicko; Sandra Kaplan; Jeffery S Sager; Robert Gallop; Jason Christie; John Hansen-Flaschen; Harold Palevsky Journal: Respir Res Date: 2005-08-10
Authors: Ahmad Sabbahi; Richard Severin; Cemal Ozemek; Shane A Phillips; Ross Arena Journal: Expert Rev Respir Med Date: 2020-01-03 Impact factor: 3.772